Free Trial

Bellerophon Therapeutics (BLPH) News Today

Bellerophon Therapeutics logo
$0.04 0.00 (0.00%)
(As of 11/20/2024 ET)
Bellerophon Therapeutics, Inc. (BLPH)
Bellerophon Therapeutics Inc (BLPH)
Bellerophon Therapeutics Inc BLPH
BLPH - Bellerophon Therapeutics, Inc.
The Latest Analyst Ratings for Bellerophon Therapeutics
Bellerophon Therapeutics, Inc. stock logo
HC Wainwright Brokers Increase Earnings Estimates for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH - Get Rating) - Stock analysts at HC Wainwright lifted their Q2 2023 EPS estimates for Bellerophon Therapeutics in a report released on Wednesday, May 17th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings per
Bellerophon Therapeutics, Inc. stock logo
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Short Interest Down 40.8% in March
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH - Get Rating) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 559,800 shares, a decline of 40.8% from the March 15th total of 945,100 shares. Based on an average trading volume of 1,210,000 shares, the days-to-cover ratio is presently 0.5 days.
H.C. Wainwright Reaffirms Their Buy Rating on Bellerophon (BLPH)
Bellerophon to Buy Rival Firm’s Shares
Short Volatility Alert: Bellerophon Therapeutics
Bellerophon Therapeutics Shares Gained Over 200% Today
Get Bellerophon Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter.

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

BLPH Media Mentions By Week

BLPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLPH
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

BLPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLPH Articles
This Week

1

0

BLPH Articles
Average Week

Get Bellerophon Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BLPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners